Skip to main navigation Skip to search Skip to main content

Multicenter, Randomized, Active-Controlled Efficacy and Safety Study Comparing Extended Duration Betrixaban With Standard of Care Enoxaparin for the Prevention of Venous Thromboembolism in Acute Medically Ill Patients

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date05/5/14 → 11/4/16

Funding

  • Portola Pharmaceuticals: $10,172.19